Summary

Active Pharmaceutical Ingredient Market Size
The global active pharmaceutical ingredient market size was valued at $162.18 billion in 2024 and is projected to reach $257.36 billion by 2030, growing at a CAGR of 8.0% during the forecast period.

Active Pharmaceutical Ingredient Market Overview
An active pharmaceutical ingredient (API) is the essential component of a pharmaceutical drug that produces the intended therapeutic effects. The API is the core substance responsible for the drug's medicinal properties and is distinct from the excipients, which are inactive substances that serve as the vehicle or medium for the API. The development and production of APIs involve intricate processes that ensure their purity, stability, and efficacy. This includes rigorous quality control and adherence to regulatory standards to guarantee that the final pharmaceutical product is safe and effective for patient use. APIs can be derived from various sources, including chemical synthesis, biotechnology, and extraction from natural materials. The effectiveness of a medication is largely dependent on the quality and concentration of its API, making it a crucial element in the pharmaceutical industry.

Active Pharmaceutical Ingredient Market Dynamics
• The active pharmaceutical ingredient market is expected to witness significant growth in the future due to the increasing prevalence of chronic diseases and aging population and the advancements in biotechnology and pharmaceutical research.
• Additionally, the rising demand for generic medications and the growth of the biopharmaceutical industry are the prominent factors driving the growth of the market.
• However, the high costs associated with API manufacturing and the competitive pressures from low-cost producers are restraining the market growth.
• On the contrary, the development of novel APIs for innovative therapies and the growing investments in advanced manufacturing technologies and processes are creating opportunities for market growth.

By End User, the Pharmaceutical & Biotechnology Industry Segment is anticipated to Hold Major Share in the Active Pharmaceutical Ingredient Market
The pharmaceutical & biotechnology industry segment is expected to dominate the market share during the forecast period owing to increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, necessitates the development and production of effective medications, which rely on high-quality APIs. Additionally, an aging global population is contributing to a greater demand for various therapeutic drugs. Technological advancements in drug discovery and biotechnology are also fueling the need for specialized and innovative APIs, enabling the development of targeted and personalized treatments. Moreover, the rise of the generic drug market, which requires cost-effective and efficient API production, is significantly contributing to this demand. The COVID-19 pandemic further highlighted the importance of robust and reliable pharmaceutical supply chains, including the need for sufficient API production to ensure drug availability. As a result, pharmaceutical and biotechnology companies are increasingly investing in the development and production of APIs to meet the growing healthcare needs and to support the creation of new and more effective therapies.

By Geography, Asia Pacific is expected to grow at a highest CAGR during the forecast period
Asia Pacific is anticipated to experience the highest compound annual growth rate during the forecast period due to the region's rapidly growing population, coupled with increasing incidences of chronic diseases and an expanding middle class with greater access to healthcare. Additionally, many countries in the Asia Pacific, such as China and India, have become major hubs for pharmaceutical manufacturing due to their cost-effective production capabilities and availability of skilled labor. These countries also offer favorable government policies and incentives to boost the pharmaceutical sector, further encouraging API production. Moreover, advancements in biotechnology and pharmaceutical research within the region are fostering innovation and the development of new drugs, which in turn requires a steady supply of high-quality APIs. The combination of these factors, along with increasing investment in healthcare infrastructure and a growing focus on improving healthcare outcomes, is fueling the robust demand for APIs in the Asia Pacific region.

Key Target Audience:
• Pharmaceutical Companies
• Biotechnology Firms
• Contract Manufacturing Organizations (CMOs)
• Regulatory Authorities
• Healthcare Providers
• Research Institutions and Academic Organizations
• API Manufacturers
• Distributors and Wholesalers

List of the Key Players Profiled in the Report Includes:
• AbbVie Inc
• AstraZeneca
• BASF SE
• Divi's Laboratories Limited
• Dr. Reddy’s Laboratories Ltd
• Eli Lilly and Company
• Evonik Industries AG
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Pfizer Inc
• Sanofi
• Teva Pharmaceutical Industries Ltd
• Viatris Inc

Recent Developments:
• In January 2024, Dr. Reddy’s announced a planned investment of Rs 700 crore (USD 84.7 Mn) towards expanding the capacity for biosimilars and Active Pharmaceutical Ingredients. Concurrently, the company has been actively developing a portfolio for biosimilars and biologics through various development deals, alongside ongoing expansions of its facilities.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Type:
• Innovative APIs
• Generic APIs

Market by, Synthesis:
• Synthetic APIs
• Biotech APIs

Market by, Type of Drug:
• Prescription
• Over the Counter

Market by, Potency:
• Traditional APIs
• High Potency APIs

Market by, Therapeutic Application:
• Cardiovascular Diseases
• Communicable Diseases
• Diabetes
• Oncology
• Pain Management
• Respiratory Diseases
• Other Therapeutic Applications

Market by, End User:
• Contract Manufacturing Organization
• Contract Research Organization
• Pharmaceutical & Biotechnology Industry
• Other End Users

Market by, Geography:
The active pharmaceutical ingredient market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

Scope of the Report:
The report “Global Active Pharmaceutical Ingredient Market: Industry Analysis, Opportunities and Forecast up to 2030” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2022, 2023 and offers revenue estimations for 2024, and project forecasts spanning from 2025 to 2030. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Active Pharmaceutical Ingredient Market by, Type
6.1 Overview
6.2 Innovative APIs
6.3 Generic APIs

7 Global Active Pharmaceutical Ingredient Market by, Synthesis
7.1 Overview
7.2 Synthetic APIs
7.3 Biotech APIs

8 Global Active Pharmaceutical Ingredient Market by, Type of Drug
8.1 Overview
8.2 Prescription
8.3 Over the Counter

9 Global Active Pharmaceutical Ingredient Market by, Potency
9.1 Overview
9.2 Traditional APIs
9.3 High Potency APIs

10 Global Active Pharmaceutical Ingredient Market by, Therapeutic Application
10.1 Overview
10.2 Cardiovascular Diseases
10.3 Communicable Diseases
10.4 Diabetes
10.5 Oncology
10.6 Pain Management
10.7 Respiratory Diseases
10.8 Other Therapeutic Applications

11 Global Active Pharmaceutical Ingredient Market by, End User
11.1 Overview
11.2 Contract Manufacturing Organization
11.3 Contract Research Organization
11.4 Pharmaceutical & Biotechnology Industry
11.5 Other End Users

12 Global Active Pharmaceutical Ingredient Market by, Geography
12.1 Overview
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 UK
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Australia
12.4.6 New Zealand
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 UAE
12.6.2 Saudi Arabia
12.6.3 Qatar
12.6.4 Iran
12.6.5 South Africa
12.6.6 Rest of Middle East & Africa

13 Key Developments

14 Company Profiling
14.1 AbbVie Inc
14.1.1 Business Overview
14.1.2 Product/Service Offering
14.1.3 Financial Overview
14.1.4 SWOT Analysis
14.1.5 Key Activities
14.2 AstraZeneca
14.3 BASF SE
14.4 Divi's Laboratories Limited
14.5 Dr. Reddy’s Laboratories Ltd
14.6 Eli Lilly and Company
14.7 Evonik Industries AG
14.8 F. Hoffmann-La Roche Ltd
14.9 Merck KGaA
14.10 Pfizer Inc
14.11 Sanofi
14.12 Teva Pharmaceutical Industries Ltd
14.13 Viatris Inc